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Atrial natriuretic peptide and other vasoactive hormones in nephrotic
syndrome. Plasma levels of atrial natriuretic peptide (ANP), arginine
vasopressin (AVP), renin activity (PRA), aldosterone (PA), catechola-
mines and urinary prostaglandins (P0), as well as renal function were
measured in children in the edematous state of the nephrotic syndrome
before and after infusion of human serum albumin. Before albumin
infusion, plasma levels of AVP, PRA, PA and noradrenaline (NA) and
urinary excretion of PGE2, PGE-Met, PGF2 were elevated. The mean
value of plasma ANP was in the normal range. Albumin infusion
produced a 36% increase in the calculated plasma volume. It was
associated with a fivefold rise in the plasma level of ANP (31.6 22.6
vs. 151.4 52 fmol/ml mean, SD), and a significant fall in the levels of
PRA, AVP, PA, and NA. Similarly, urinary concentration of POE2,
POE-Met and PGF2,. fell. Urine flow, GFR, UNV, FEN, and Cø,m
increased significantly, while CH,O remained unchanged. The diuresis,
natriuresis and GFR correlated with the level of plasma ANP, while
urinary sodium excretion did not correlate with PA or NA levels. These
findings suggest that ANP plays an important role in albumin induced
natriuresis in children with nephrotic syndrome.
The pathogenesis of the nephrotic syndrome (NS) has not
been fully elucidated. The cause and treatment of severe edema
accompanying the NS have been subjects of controversy for
many years. Alterations in vasoactive hormone systems, such
as renin—angiotensin—aldosterone system (RAAS), arginine
vasopressin (AVP) and catecholamines may all contribute to
the sodium and fluid retention [1—4].
More recently a new hormone, atrial natriuretic peptide
(ANP), has been discovered which may play a crucial role in
fluid and electrolyte homeostasis. The hormone is released from
the atria of mammals following distension of the atrial wall,
contains 28 aminoacids in the human and has a potent natri-
uretic and diuretic effect [5—8]. ANP has a vasodilating activity
in vitro, inhibits the vasoconstrictor actions of angiotensin II
and noradrenaline (NA), decreases plasma renin activity
(PRA), and reduces secretion of aldosterone and arginine
vasopressin [9—11]. The exact role of ANP in the pathophysiol-
ogy of renal diseases associated with changes in the body fluid
compartments has not yet been extensively investigated. In a
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recent paper however, we have shown that expansion of the
extracellular fluid volume in children with chronic renal failure
correlates with the increase in plasma levels of ANP [12].
The aim of the present study was to examine the effect of
rapid changes in plasma volume on plasma ANP in children.
Albumin infusion has been shown to produce an immediate
sodium and water diuresis by increasing effective central
blood—volume in children with nephrotic syndrome. Since
central blood—volume expansion is known to be a major stim-
ulus for ANP release, we tested whether ANP is involved in the
albumin—induced renal sodium and water excretion in children.
In addition, besides renal characteristics, several other hor-
mones involved in sodium and water homeostasis were studied.
Methods
Patients
Nine children with NS were included in this study. Three
patients were investigated during their first episode of NS
(patients 1, 2, 3), and the remaining six during relapses as
defined by the International Study of Kidney Disease in Chil-
dren [13]. All had a clinical history of heavy proteinuria ( 40
mg/m2/hr), and hypoalbuminemia ( 25 g/liter). None had
hypertension or persistent hematuria. At the time of the study
edema was present in all, as documented by a weight gain
between 4.0 and 16.6% during the previous three days. Further
clinical and renal biopsy data are given in Table 1. None of the
patients had received corticosteroids, diuretics or albumin
infusion prior to the study, All children were investigated
before and after the infusion of 20% human serum albumin in a
dose of 1.0 g/kg over 90 minutes, as a part of therapeutic
regimens. Urine collection was carried out for 12 hours before
the albumin infusion and again for six hours after the end of the
infusion. Blood samples were taken at the midpoint of each of
these two periods. Urine and blood samples were analyzed for
creatinine, sodium, chloride, total protein and albumin by
conventional laboratory methods. Plasma osmolality was mea-
sured by a vapor pressure osmometer (Wescor 5100 C).
Radioimmunoassays were used for measuring plasma concen-
trations of ANP [14], AVP [15], PRA [16], and PA [17]. Urinary
prostaglandin concentrations were determined by mass spec-
trometry [18]. Catecholamine measurements were carried out
by a radioemzymatic method [19]. Calculations of clearances
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Table 1. Clinical data of children with idiopathic nephrotic syndrome
H. M. M 2;4 12.0 16.6 —
H. B. M 4;2 16.0 10.0 FSGS
W. J. M 4;10 25.0 14.8 —
W. M. F 5;6 17.0 5.9 MC
R. T. F ll;8 30.0 12.3 MC
R. T. F 1l;9 30.0 4.0 MC
H. A. F l3;0 45.0 4.4 MC
B. M. M 16;4 57.0 9.6 MC
B. C. F 17;8 50.0 19.8 MC
Abbreviations are: MC, minimal glomerular changes; FSGS, focal
segmental glomerulosclerosis.
(Ccr Cosm, CH2O) and fractional excretion of solutes and water
(FENa, FEc1, FEH,O) were made using conventional formulas.
Percent change in plasma volume (PV) was calculated from
concomitant hemoglobin (Hb) and hematocrit (Ht) concentra-
tions, using the formula of Strauss et al [20]:
Hb (g/dl) before 1-Ht (liter/liter) after%PV=100 x —100
Hb (g/dl) after 1-Ht (liter/liter) before
Values are given as mean SD. Student's 1-test for paired data
was used for statistical evaluation. Linear regression analysis
was done by means of the method of the least squares.
Results
Following albumin infusion systolic blood pressure remained
unchanged, but diastolic blood pressure rose (Table 2). Plasma
albumin and total protein concentrations increased from
19.0±2.2 to 23.4±4.9 g/liter and from 42.1±5.3 to 49.8±8.9
g/liter, respectively. Hb and Ht values decreased significantly
(Table 2). There was a significant increase in GFR as deter-
mined by CCr, in urine output (U) and in FEH2O. There were
also increases in the absolute amount and in the fractional
excretion of sodium and chloride in the urine, while plasma
values did not change (Na, 138±2.1 vs. 139.3±1.6; Cl, 98.8±4.6
vs. 100.7±4.0 mmol/liter). Free water clearance (C2o) and
plasma osmolality (P0sm) did not change significantly, whereas
Cosm rose and urine osmolality (Uosm) fell significantly. Protein
excretion increased more than threefold (Table 3).
Before albumin infusion the plasma level of ANP was
31.6±22.6 fmollml which is not significantly different from the
age—related normal values (25.2±10.5 fmoLlml, N=30). In four
patients plasma ANP level was below the normal range; in two
children however, elevated values were measured. After albu-
min infusion the mean plasma ANP increased fivefold, to
151.4±52 fmol/ml. Changes in the plasma concentration of ANP
are compared with those of other vasoactive hormones in Table
4. PRA, PA, AVP and NA levels decreased significantly after
albumin infusion while adrenaline and dopamine remained
unchanged.
Significant positive correlations were found between plasma
ANP on one hand and urine volume (r=0.64, P<0.Ol), Ccr
(r=0.62, P<0.01) and UNaV (r=0.62,P<0.01, Fig. 1) on the
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other. PRA correlated with UNaV (r=0.49 P<0.05) but we did
not observe a significant correlation between UNaV and PA
(r0.04) or plasma NA levels (r0.30). Plasma ANP showed a
negative correlation with PRA (r=0.52, P<0.05), and there
were no significant correlations between PRA and PA (r0.41),
ANP and NA (r=0.43), or ANP and AVP (r=0.42).
Among the urinary prostaglandins, absolute POE2 excretion
increased significantly whereas urine POE2 concentrations de-
creased (Table 5). PGF2a and PGE-Met similarly showed a fall
in concentration after albumin infusion.
Discussion
We examined the possible roles of vasoactive hormones,
including ANP, in NS by comparing their plasma concentra-
tions before and after albumin infusion as a means to increase
plasma volume during the edematous state. Although changes
in plasma volume were indirectly estimated, the data suggest
that in fact a significant rise occurred after albumin infusion.
Moreover, the pre-infusion high levels of NA, AVP and PRA
are consistent with a decreased, effective circulatory plasma—
volume. Apparently albumin infusion led to a redistribution of
body water from the interstitial space to the intravascular
compartment because the estimated changes in plasma volume
occurred in the absence of significant changes in body weight.
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Fig. 1. Relationship between atria! natriuretic peptide (ANP) and
sodium excretion (UNaV) in children with nephrotic syndrome before
() and after (0) human serum albumin infusion.
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Table 2. Changes in blood pressure and biochemical findings of blood and glomerular filtration rate (Ccr) in children
with nephrotic syndrome before and after infusion of albumin (1.0 g/kg)
Systolic blood Diastolic blood plasma total plasma
pressure pressure albumin proteins Hb Ht Ccr
mm Hg mm Hg g/liter g/iiter gIdi % ml/min/1.73 m2
Before albumin 110 71 19.0 42.1 13.9 41.2 104
±13 ±7 ±2.2 ±5.3 ±1,2 ±3.6 ±28
After albumin Ill 79 23.4 49.8 11.5 33.8 221
±11 ±5 ±4.9 ±8.9 ±0.9 ±2.0 ±75
P value NS <0.001 <0.001 <0.02 <0.001 <0.001 <0.01
Table 3. Excretion (UV) and fractional excretion (FE) of water, sodium, and chloride, and clearances of water and solutes
in children with nephrotic syndrome before and after albumin infusion
FEH,o UNaV FENa UiV FE1 CH,o Com, Uosm UproteinsV
ml/min/l.73 m2 %' ,.unoi/min/1.73 m2 % pmol/min/I.73 m2 % mi/min/1,73 m2 mOsm/kg mg/min/1.73 m2
Before albumin 0.67 0.7 51.4 0.37 47.6 0.47 —0.67 1.34 755 293 1.19
±0.45 ±0.5 ±24.1 ±0.16 ±23.9 ±0.23 ±0.51 ±0.22 ±301 ±9.8 ±0.5
After albumin 2.51 1.35 248 0.94 223 1.15 —0.94 3.45 495 299 3.8
±1.20 ±0.9 ±109 ±0.63 ±89 ±0.69 ±1.2 ±0.7 ±201 ±10.7 ±1.7
P value <0.001 <0.01 <0,001 <0.001 <0.001 <0.02 NS <0.001 <0.01 NS <0.001
Similar clinical observations have been made earlier during
albumin infusion in NS [2 1—23].
Among the hormonal changes observed during administration
of albumin the most striking was the fivefold increase in plasma
ANP concentration. The increase of ANP was associated with
changes in kidney function similar to those seen after adminis-
tration of ANP to normal human subjects and experimental
animals: increases in urine volume, in sodium excretion and in
GFR [9, 10, 24, 25]. The rise in sodium excretion was accom-
panied by an increased fractional excretion, suggesting that
besides increased filtration, tubular mechanisms were also
involved.
In recent years it has been proposed that intrarenal factors
may be involved in the retention of sodium in the NS [26—29]. It
has been suggested that the defect is localized to the distal
nephron segments, since sodium reabsorption in the proximal
tubules is either normal or even depressed [23, 29—32]. These
observations are compatible with an important role in edema
formation for ANP, the natriuretic action of which, according to
micropuncture studies, may be restricted to the medullary
collecting ducts [33].
A weak, but significant correlation was demonstrated be-
tween ANP and UNaV even in this small number of patients.
Such a relation could not be observed between PA and UNaV.
These findings may suggest a role of ANP in mediating
albumin-.induced natriuresis in nephrotic children. It is also of
interest that, after administration of atrial extracts in rats, urea
concentration in the renal papilla decreases [34]. This is con-
sistent with our observation of a threefold increase in osmolar
clearance without major changes in free water clearance during
infusion of albumin, and supports other data [35, 36] suggesting
that ANP leads to a wash—out of the inner medulla. A high fluid
load delivered to a relatively "washed—out" medulla may well
explain the ANP-induced rise of natriuresis after albumin
infusion.
Table 4. Changes in plasma levels of vasoactive hormones in children
with nephrotic syndrome before and after albumin infusion
Before
albumin
After
albumin P value
ANP,fmoi/mi 31.6 ± 22.6 151.4 ± 52 <0.001
PRA, ng Ang 1/mi/hr 5.6 ± 2.7 1.9 ± 0.89 <0.01
PA, ng/di 16.3 ± 9.5 5.9 ± 3.6 <0.01
AVP, pg/mi 16.9 ± 13.6 4.9 ± 4.1 <0.02
Noradrenaline, pg/mi 276.0 ± 95.5 156.2 ± 64.9 <0.01
Adrenaline, pg/mi 78.3 ± 53.7 50.4 ± 19.2 NS
Dopamine, pg/mi 217.4 ± 70.4 176.8 ± 52.6 NS
The increase of creatinine clearance following albumin infu-
sion may simply reflect the diuretic response. It may also be due
to a reversal of the lower filtration coefficient reported in the NS
[29]. A further explanation is offered by the physiological effect
of ANP to increase GFR without changes in renal blood flow
[10, 33, 35, 36] by constricting the efferent and/or dilating the
afferent arterioles of the glomerulus [37].
An interpretation of how prostaglandins are involved in the
natriuretic response of nephrotic patients to albumin infusion is
difficult, since prostaglandin excretion is quite dependent on
urine flow rate [38, 39]. Therefore, we report, in addition to
absolute PG excretion, the urinary prostaglandin concentra-
tions. All the urinary prostaglandin concentration data show a
similar trend: PGE2, PGE-Met and PGF2a were high before
albumin infusion and decreased afterwards. The biological
significance of the high level of vasodilatatory prostaglandins
originating in the renal medulla is to protect the kidney from the
vasoconstrictor effects of high concentration of NA, angioten-
sin II and AVP, and to supply adequate tissue perfusion.
It appears that the common mechanism which triggers all the
hormonal changes described in this study is probably the
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Table 5. Urinary prostaglandin excretion in children with nephrotic
syndrome before and after albumin infusion
Before
albumin
After
albumin P value
PGE2, ng/hr/1.73 m2 24.6 11.2 44.2 19.5 <0.05
PGE2/U, ng/ml 0.71 0.45 0.39 0.28 <0.02
PGF2,,, ng/hr/1.73 m2 50.0 5.8 103.0 90.0 NS
PGF2jU, ng/m! 1.54 0.83 0.76 0.55 <0.02
POE-Met, ng/hr/I.73 m2 274.0 183.0 234.0 208.0 NS
PGE-Met/U, ng/ml 10.1 9.5 1.9 1.6 <0.05
Values are given as absolute amount excreted and in relation to urine
volume.
Abbreviation is: PGE-Met, 7a-hydroxy-5, 1 1-diketotetranorprostane-
1,16-dioic acid
increase in effective central blood—volume, resulting in an
elevation in the central venous pressure. The process may be
analogous to the head—out water immersion, where similar
changes were described [40, 41]. The rise in atrial pressure
causes release of ANP into the circulation, the rise in blood
volume suppresses plasma levels of vasoconstrictor hormones,
which in turn lowers medullary prostaglandin synthesis.
In conclusion, infusion of human albumin to children with
nephrotic syndrome causes changes in plasma concentrations
of several vasoactive and natriuretic hormone—systems. Among
them, the increase in plasma concentration of ANP may medi-
ate albumin—induced water and sodium diuresis.
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